rs768295360
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_005422.4(TECTA):c.2139C>A(p.Cys713Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,612,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005422.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TECTA | NM_005422.4 | c.2139C>A | p.Cys713Ter | stop_gained | 9/24 | ENST00000392793.6 | |
TBCEL-TECTA | NM_001378761.1 | c.3096C>A | p.Cys1032Ter | stop_gained | 15/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.2139C>A | p.Cys713Ter | stop_gained | 9/24 | 5 | NM_005422.4 | P4 | |
TECTA | ENST00000264037.2 | c.2139C>A | p.Cys713Ter | stop_gained | 8/23 | 1 | P4 | ||
TECTA | ENST00000642222.1 | c.2139C>A | p.Cys713Ter | stop_gained | 9/24 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460642Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726668
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 18, 2021 | This sequence change creates a premature translational stop signal (p.Cys713*) in the TECTA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TECTA are known to be pathogenic (PMID: 11087000, 12746400, 17431902, 24130743). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with TECTA-related conditions. ClinVar contains an entry for this variant (Variation ID: 505476). For these reasons, this variant has been classified as Pathogenic. - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 12, 2017 | The p.Cys713X variant in TECTA has not been previously reported in individuals w ith hearing loss or in large population studies. This nonsense variant leads to a premature termination codon at position 713, which is predicted to lead to a t runcated or absent protein. Loss of function of the TECTA gene is an established disease mechanism in autosomal recessive hearing loss. In addition, some varian ts that result in a truncated protein may have the potential to cause hearing lo ss inherited in an autosomal dominant pattern (Collin 2008, Hildebrand 2011). Ho wever, there is insufficient evidence to predict whether the p.Cys713X variant c an lead to dominantly inherited hearing loss. In summary, this variant meets our criteria to be classified as pathogenic for hearing loss in an autosomal recess ive manner based on the predicted impact on the protein. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at